[%hDId%] 

1Q25 result was bad beyond words, the company even recorded operating loss (the first time since IPO(?)).

In the last few quarters [%tTeU%] has been struggling with:
- Fierce competition landscape with many newly-emerged Lab post-covid offering Medical check up with competitive price.
- In the last one year many hospitals has been very aggressive promoting MCU with significant discount and promotion.
- From the inside of the company, PRDA has been struggling with significant expense addition from IT-related App project which so far has not been proven giving additional income-stream to the company.

and what the management of [%XOkA%] has been doing lately?
Instead of focusing on business development and cutting cost (which they really need to do it badly), they are doing IDR200bn share buyback aggressively! 

The management needs to realize what's more important is recording a healthy business operating profit, not just spending money on buybacks.

$PRDA 

1Q25 result was bad beyond words, the company even recorded operating loss (the first time since IPO(?)).

In the last few quarters $PRDA has been struggling with:
- Fierce competition landscape with many newly-emerged Lab post-covid offering Medical check up with competitive price.
- In the last one year many hospitals has been very aggressive promoting MCU with significant discount and promotion.
- From the inside of the company, PRDA has been struggling with significant expense addition from IT-related App project which so far has not been proven giving additional income-stream to the company.

and what the management of $PRDA has been doing lately?
Instead of focusing on business development and cutting cost (which they really need to do it badly), they are doing IDR200bn share buyback aggressively! 

The management needs to realize what's more important is recording a healthy business operating profit, not just spending money on buybacks.